|
ZNF81 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.463630E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.809500E-02 |
| Normal-vs-Stage2 |
9.028800E-01 |
| Normal-vs-Stage3 |
3.594800E-01 |
| Normal-vs-Stage4 |
2.038200E-01 |
| Stage1-vs-Stage2 |
5.362000E-01 |
| Stage1-vs-Stage3 |
7.996000E-01 |
| Stage1-vs-Stage4 |
5.616600E-01 |
| Stage2-vs-Stage3 |
6.591800E-01 |
| Stage2-vs-Stage4 |
4.359600E-01 |
| Stage3-vs-Stage4 |
5.156400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.378950E-01 |
| Normal-vs-AfricanAmerican |
2.837800E-01 |
| Normal-vs-Asian |
1.110790E-01 |
| Caucasian-vs-AfricanAmerican |
9.370600E-01 |
| Caucasian-vs-Asian |
6.243000E-01 |
| AfricanAmerican-vs-Asian |
6.905600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.527980E-02 |
| Normal-vs-Female |
3.821000E-01 |
| Male-vs-Female |
8.555600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.485380E-01 |
| Normal-vs-Extreme_Weight |
8.821600E-03 |
| Normal-vs-Obese |
8.956000E-01 |
| Normal-vs-Extreme_Obese |
2.218000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.402400E-01 |
| Normal_Weight-vs-Obese |
2.438800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.507600E-01 |
| Extreme_Weight-vs-Obese |
3.620300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.691000E-01 |
| Obese-vs-Extreme_Obese |
6.800200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.175000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.518000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.363610E-02 |
| Normal-vs-Age(81-100Yrs) |
2.757200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.155200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.032000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.303050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.393570E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.836500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.516400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.726100E-02 |
| Normal-VS-Type2 PRCC |
2.867500E-02 |
| Normal-VS-KIRP CIMP |
8.194400E-02 |
| Normal-VS-Unclassified PRCC |
2.287800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.350400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.695200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.932400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.992800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.090100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.154000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.242240E-02 |
| Normal-vs-N1 |
8.485800E-01 |
| Normal-vs-N2 |
1.747030E-01 |
| N0-vs-N1 |
1.351370E-01 |
| N0-vs-N2 |
9.530600E-01 |
| N1-vs-N2 |
5.172400E-01 |
|
|
